Lilly Updates Open Letter Regarding the Use of Tirzepatide for Cosmetic Weight Loss

Eli Lilly continues to emphasize the potential harm that could come with using GLP-1 receptor agonists for off-label purposes.

Source link
#Lilly #Updates #Open #Letter #Tirzepatide #Cosmetic #Weight #Loss